Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · September 24, 2022

Improvement in HRQoL With Dupilumab in Patients With Moderate to Severe Asthma With Comorbid Chronic Rhinosinusitis With/Without Nasal Polyps

Journal of asthma and allergy


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of asthma and allergy
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study
J Asthma Allergy 2022 Sep 01;15(xx)767-773, C Hopkins, KM Buchheit, E Heffler, NA Cohen, H Olze, AH Khan, J Msihid, S Siddiqui, S Nash, JA Jacob-Nara, PJ Rowe, Y Deniz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading